Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine set out in the Schedule hereto:
Schedule
Product: | Faslodex |
Active Ingredient: | Fulvestrant 50mg/mL |
Dosage Form: | Solution for injection |
New Zealand Sponsor: | AstraZeneca Limited |
Manufacturer: | Vetter Pharma-Fertigung GmbH & Co KG, Ravensburg, Germany Vetter Pharma-Fertigung GmbH & Co KG, Langenargen, Germany |
Product: | Fluzone High-Dose |
Active Ingredients: | Influenza virus A/Michigan/45/2015 (H1N1) pdm09 - like strain 60mcg Influenza virus A/Singapore/INFIMH-16-0019/2016 (H3N2) - like strain 60mcg Influenza virus B/Phuket/3073/2013 - like strain 60mcg |
Dosage Form: | Suspension for injection |
New Zealand Sponsor: | Sanofi-aventis New Zealand Limited |
Manufacturer: | Sanofi Pasteur Inc, Pennsylvania, United States of America |
Dated this 15th day of July 2020.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on the 11 September 2013).